These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 33245866

  • 1. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
    Vanobberghen F, Lweno O, Kuemmerle A, Mwebi KD, Asilia P, Issa A, Simon B, Mswata S, Schmidlin S, Glass TR, Abdulla S, Daubenberger C, Tanner M, Meyer-Monard S.
    Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
    [Abstract] [Full Text] [Related]

  • 2. Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial.
    Afolabi BB, Adaramoye VO, Adeyemo TA, Balogun M, Mitchell EJ, Walker K, Akinajo OR, Abioye IA, Banke-Thomas A, Babah OA, Chieme CF, Oshodi Y, Quao R, Eboreime EA, Ogunsola F.
    BMJ Open; 2024 Aug 17; 14(8):e086553. PubMed ID: 39153791
    [Abstract] [Full Text] [Related]

  • 3. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC.
    Semin Hematol; 2018 Oct 17; 55(4):223-234. PubMed ID: 30502851
    [Abstract] [Full Text] [Related]

  • 4. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
    Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.
    Lancet Haematol; 2016 Sep 17; 3(9):e415-25. PubMed ID: 27570088
    [Abstract] [Full Text] [Related]

  • 5. Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial.
    Afolabi BB, Babah OA, Adeyemo TA, Balogun M, Banke-Thomas A, Abioye AI, Akinajo OR, Galadanci HS, Quao RA, Adelabu H, Sam-Agudu NA, Adaramoye VO, Abubakar A, Banigbe B, Olorunfemi G, Beňová L, Larsson EC, Annerstedt KS, Hanson C, Thornton J, IVON Trial Investigators.
    Lancet Glob Health; 2024 Oct 17; 12(10):e1649-e1659. PubMed ID: 39304237
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
    Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM, Kaserer A, Hegemann I, Hofmann A, Maisano F, Falk V.
    Lancet; 2019 Jun 01; 393(10187):2201-2212. PubMed ID: 31036337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Pasricha SR, Mwangi MN, Moya E, Ataide R, Mzembe G, Harding R, Zinenani T, Larson LM, Demir AY, Nkhono W, Chinkhumba J, Simpson JA, Clucas D, Stones W, Braat S, Phiri KS.
    Lancet; 2023 May 13; 401(10388):1595-1609. PubMed ID: 37088092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous ferric carboxymaltose for anaemia in pregnancy.
    Froessler B, Collingwood J, Hodyl NA, Dekker G.
    BMC Pregnancy Childbirth; 2014 Mar 25; 14():115. PubMed ID: 24667031
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P, Rumyantsev V.
    Arzneimittelforschung; 2010 Mar 25; 60(6a):373-85. PubMed ID: 20648929
    [Abstract] [Full Text] [Related]

  • 17. Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice.
    Stein J, Aksan A, Klemm W, Nip K, Weber-Mangal S, Dignass A.
    J Crohns Colitis; 2018 Jun 28; 12(7):826-834. PubMed ID: 29955835
    [Abstract] [Full Text] [Related]

  • 18. Real-world efficacy and safety of intravenous ferric carboxymaltose for the management of iron deficiency anaemia in Malaysia: A single centre cohort study.
    Kamarul HNB.
    Med J Malaysia; 2024 Sep 28; 79(5):517-524. PubMed ID: 39352152
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.
    Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD.
    Nephrol Dial Transplant; 2011 May 28; 26(5):1599-607. PubMed ID: 20929915
    [Abstract] [Full Text] [Related]

  • 20. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.
    Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD, FIND-CKD Study Investigators.
    Nephrol Dial Transplant; 2014 Nov 28; 29(11):2075-84. PubMed ID: 24891437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.